Trial Profile
To evaluate the immune response induced by Cetuximab at liver metastasis sites in patients with metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2017
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 18 May 2017 New trial record